Recent Finacing
Recent Raise
Chondrogenix develops cell therapies for osteoarthritis by transdifferentiating patient and donor cells into hyaline chondrocytes using the Mogrify platform and small-molecule cocktails for autologous, allogeneic and in vivo reprogramming.
Focus Areas
Recent Investors
Funding round
Investor